Joseph Calabrese MD

Research Chair, Bipolar Disorders, Case Western Reserve University

Lurasidone for Bipolar Depression

John Zajecka MD

Associate Professor of Psychiatry Rush University Medical Center

Clinical Implications of Cognitive Disturbances in Major Depression

Roger McIntyre MD

Professor of Psychiatry, University of Toronto

Innovative Strategies for Treating Cognitive Disturbances in Major Depression

Connie Sanchez PhD

Vice President, Lundbeck Research

Preclinical Profile of Vortioxetine and Role in Cognition

Dan Iosifescu MD

Associate Professor of Psychiatry, Icahn School of Medicine

Rapidity of Response to Lurasidone in Bipolar Depression

Paul Keck MD

CEO, Lindner Center, Cincinnati, OH

Update on Binge Eating Disorder

Joseph Biederman MD

Professor of Psychiatry, Harvard Medical School

Controversies in Pediatric Bipolar Disorder

Eduard Vieta MD

Professor of Psychiatry, University of Barcelona

ISBD Guidelines for Antidepressant Use in Bipolar Disorder

Michael Thase MD

Professor of Psychiatry, University of Pennsylvania

Brexipiprazole as an Adjunct in Treatment Resisitant Depression

Ashwin Patkar MD

Associate Professor of Psychiatry, Duke University Medical Center

Switching Strategies to Different Doses of Vilazodone

Patrick McGorry MD

Professor of Psychiatry, University of Melbourne

Early Interventions in Psychosis

Andrew Cutler MD

Medical Director, Florida Clinical Research Center

Levomilnacipran and Functional Improvement in Major Depression

Rakesh Jain MD

Associate Clinical Professor of Psychiatry, University of Texas Medical Center

Role of L-Methylfolate as an Adjunct in Treatment Resistant Depression

Susan McElroy MD

Chief of Research, Lindner Center, Cincinnati, OH.

Metabolic Effects of Lurasidone

E. Fuller Torrey MD

Founder, Treatment Advocacy Center

Challenges to Mental Health Treatment in the US

Angelo Sambunaris MD

Medical Director, Atlanta Institute of Medicine and Research, Atlanta

Update on the Anxiolytic Effects of Vilazodone

Donald Black MD

Professor of Psychiatry, University of Iowa

Management of Antisocial Personality Disorder

Donald Black MD

Professor of Psychiatry, University of Iowa

Pharmacotherapy of Borderline Personality Disorder

Michael Ostacher MD

Associate Professor of Psychiatry, Stanford University

LITMUS and BALANCE Studies

Eduard Vieta MD

Professor of Psychiatry, University of Barcelona

Role of Functional Remediation in Bipolar Disorder

Thomas Wise MD

Professor of Psychiatry, Johns Hopkins University

Clinical Pearls in Psycho-Oncology

GME Presents Exclusive Highlights from the 22nd
European Congress of Psychiatry held on March 1-4, 2014

Greg Lydall MD

Consultant Addictions Psychiatrist, Guernsey

Illicit Use of Prescription and OTC Drugs

Peter Falkai MD

Professor of Psychiatry, Ludwig Maxmilians University

Biomarkers in Psychiatric Illnesses

Roger S. McIntyre MD

Professor of Psychiatry, University of Toronto

Cognitive and Metabolic Impairments in Bipolar Disorder

Wolfgang W. Fleischhacker MD

Professor of Psychiatry, Innsbruck University Clinics

New Developments in the Treatment of Schizophrenia

Joseph Calabrese MD

John Zajecka MD

Roger McIntyre MD

Connie Sanchez PhD

Dan Iosifescu MD

Paul Keck MD

Joseph Biederman MD

Eduard Vieta MD

Michael Thase MD

Ashwin Patkar MD

Patrick McGorry MD

Andrew Cutler MD

Rakesh Jain MD

Susan McElroy MD

E. Fuller Torrey MD

Angelo Sambunaris MD

Donald Black MD

Donald Black MD

Michael Ostacher MD

Eduard Vieta MD

Thomas Wise MD

GME Presents Exclusive Highlights from the 22nd European Congress of Psychiatry held on March 1-4, 2014

Greg Lydall MD

Peter Falkai MD

Roger S. McIntyre MD

Wolfgang W. Fleischhacker MD

GME Presents Exclusive Highlights from the 22nd
European Congress of Psychiatry held on March 1-4, 2014